Anika Therapeutics (ANIK) Tops Q3 EPS by 22c
Tweet
Share
E-mailGet Alerts ANIK Hot Sheet
Price: $14.61 +2.89%
Revenue Growth %: +3.5%
Financial Fact:
Comprehensive income (loss): 9.26M
Today's EPS Names:
MAYS, CRMT, REPL, More
Revenue Growth %: +3.5%
Financial Fact:
Comprehensive income (loss): 9.26M
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Anika Therapeutics (NASDAQ: ANIK) reported Q3 EPS of $0.04, $0.22 better than the analyst estimate of ($0.18). Revenue for the quarter came in at $27.8 million versus the consensus estimate of $27.8 million.
For earnings history and earnings-related data on Anika Therapeutics (ANIK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump on Iran: we're trying to work out a deal that's fair
- Active options: MSFT PLTR META GOOGL SOFI MSTR IREN AMC IBM SMCI HOOD AMD
- Ross Stores (ROST) call put ratio 1 call to 1 put as share price down 3%
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
